Publications | ProMab

ProMab's goal to become one of the leading providers in CAR-T research & immunotherapy space allows us to post our findings on accredited research publications.

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells.

Xi B, Berahovich R, Zhou H, Xu S, Wei Y, Guan J, Harto H, Guan J, Wu L, Santa Ana D, Cerignoil F, Lamarche B4, Abassi YA, Golubovskaya V.

Hypoxia Selectively Impairs CAR-T Cells In Vitro.

Berahovich R, Liu X, Zhou H, Tsadik E, Xu S, Golubovskaya V, Wu L.

Generation of CAR-T Cells for Cancer Immunotherapy.

Xu Q, Harto H, Berahovich R, Xu S, Zhou H, Golubovskaya V, Wu L.

CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth.

Berahovich R, Zhou H, Xu S, Wei Y, Guan J, Guan J, Harto H, Fu S, Yang K, Zhu S, Li L, Wu L, Golubovskaya V.

GITR domain inside CAR co-stimulates activity of CAR-T cells against cancer.

Golubovskaya VM, Berahovich R, Xu Q, Zhou H, Xu S, Guan J, Harto H, Li L, Wu L.

CAR-T Cell Therapy: From the Bench to the Bedside.

Golubovskaya V.

CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.

Golubovskaya V, Berahovich R, Zhou H, Xu S, Harto H, Li L, Chao CC, Mao MM, Wu L.

FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells in vitro and in vivo.

Berahovich R, Xu S, Zhou H, Harto H, Xu Q, Garcia A, Liu F, Golubovskaya VM, Wu L.

Major Highlights of the CAR-TCR Summit, Boston, 2016.

Golubovskaya V, Berahovich R, Xu S, Harto H, Wu L.

Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy.

Golubovskaya V, Wu L.

Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells in vitro and in vivo.

Valentine M., Le Li,, Hua Zhou, Shirley Xu, Jinying Sun, Chengjing Liu, Hizkia Harto, Robert Berahovich, Vita Golubovskaya, Lijun Wu,